Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults

被引：0
|
作者：
Sze P. Tsui
Ho W. Ip
Nicole Y. Saw
Chunxiao Zhang
Arthur K. Cheung
Nelson K. Ng
Cheuk H. Man
Stephen S. Lam
Wing F. Tang
Chi H. Lin
Grace H. Cheng
Chun H. Au
Edmond S. Ma
Tsun L. Chan
Jason C. So
Margaret H. Ng
Kelvin C. Cheng
Kit F. Wong
Lai P. Siu
Sze F. Yip
Shek Y. Lin
June S. Lau
Tsan H. Luk
Harold K. Lee
Chi K. Lau
Bonnie Kho
Joycelyn P. Sim
Yok L. Kwong
Suet Y. Leung
Asif Javed
Anskar Y. Leung
机构：
[1] Queen Mary Hospital,Department of Pathology
[2] The University of Hong Kong,School of Biomedical Sciences, LKS Faculty of Medicine
[3] The University of Hong Kong,Division of Haematology, Department of Medicine, LKS Faculty of Medicine
[4] The University of Hong Kong,Centre for PanorOmic Sciences, LKS Faculty of Medicine
[5] The University of Hong Kong,The Jockey Club Centre for Clinical Innovation and Discovery, LKS Faculty of Medicine
[6] Hong Kong Sanatorium and Hospital,Department of Pathology
[7] Hong Kong Children’s Hospital,Department of Pathology
[8] The Chinese University of Hong Kong,Department of Anatomical and Cellular Pathology
[9] Queen Elizabeth Hospital,Department of Pathology
[10] Tuen Mun Hospital,Department of Pathology
[11] United Christian Hospital,Department of Medicine and Geriatrics
[12] Queen Elizabeth Hospital,Department of Medicine
[13] Princess Margaret Hospital,Department of Medicine
[14] Tseung Kwan O Hospital,Department of Medicine
[15] Pamela Youde Nethersole Eastern Hospital,Department of Medicine
[16] The University of Hong Kong,Department of Pathology, LKS Faculty of Medicine
来源：
Blood Cancer Journal | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Immunity In Cytogenetically Normal Acute Myeloid Leukemia (iCN-AML)
    Ting, Stephen
    Lee, Denise
    Low, Michael
    Ling, Yee-May
    Trung Nguyen
    McQuilten, Zoe K.
    Cody, Stephen
    McLean, Catriona
    BLOOD, 2013, 122 (21)
  • [32] Genetic Markers in Older Cytogenetically Normal Acute Myeloid Leukemia Patients
    Becker, H.
    Marcucci, G.
    Bloomfield, C. D.
    ANNALS OF HEMATOLOGY, 2013, 92 : S30 - S33
  • [33] Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
    Santamaria, Carlos M.
    Chillon, Maria C.
    Garcia-Sanz, Ramon
    Perez, Cristina
    Caballero, Maria D.
    Ramos, Fernando
    Garcia de Coca, Alfonso
    Alonso, Jose M.
    Giraldo, Pilar
    Bernal, Teresa
    Queizan, Jose A.
    Rodriguez, Juan N.
    Fernandez-Abellan, Pascual
    Barez, Abelardo
    Penarrubia, Maria J.
    Balanzategui, Ana
    Vidriales, Maria B.
    Sarasquete, Maria E.
    Alcoceba, Miguel
    Diaz-Mediavilla, Joaquin
    San Miguel, Jesus F.
    Gonzalez, Marcos
    BLOOD, 2009, 114 (01) : 148 - 152
  • [34] Prognostically Important Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia
    Lin, Tara L.
    Smith, B. Douglas
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (05): : 404 - 408
  • [35] Prognostic significance of BAALC expression in cytogenetically normal acute myeloid leukemia
    Chopra, Anita
    Verma, Deepak
    Kumar, Rajive
    Singh, Jay
    Ali, Shadab
    Bakhshi, Sameer
    Sharma, Atul
    Palanichamy, Jayanth Kumar
    Sharawat, Surender Kumar
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 78 - 79
  • [36] Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia
    Christoph W. M. Reuter
    Jürgen Krauter
    Fredrick O. Onono
    Tania Bunke
    Frederik Damm
    Felicitas Thol
    Katharina Wagner
    Gudrun Göhring
    Brigitte Schlegelberger
    Michael Heuser
    Arnold Ganser
    Michael A. Morgan
    Annals of Hematology, 2014, 93 : 977 - 982
  • [37] Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
    Wen-Chi Yang
    Wan-Chi Tsai
    Pai-Mei Lin
    Ming-Yu Yang
    Yi-Chang Liu
    Chao-Sung Chang
    Wen-Hui Yu
    Sheng-Fung Lin
    Journal of Biomedical Science, 20
  • [38] Improving the molecular risk classification for younger (<60 years) de novo cytogenetically normal acute myeloid leukemia (CN AML) patients (pts)
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Paschka, P.
    Baldus, C. D.
    Langer, C.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
    Yang, Wen-Chi
    Tsai, Wan-Chi
    Lin, Pai-Mei
    Yang, Ming-Yu
    Liu, Yi-Chang
    Chang, Chao-Sung
    Yu, Wen-Hui
    Lin, Sheng-Fung
    JOURNAL OF BIOMEDICAL SCIENCE, 2013, 20
  • [40] Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
    Ferraro, Francesca
    Miller, Christopher A.
    Christensen, Keegan A.
    Helton, Nichole M.
    O'Laughlin, Margaret
    Fronick, Catrina C.
    Fulton, Robert S.
    Kohlschmidt, Jessica
    Eisfeld, Ann-Kathrin
    Bloomfield, Clara D.
    Ramakrishnan, Sai Mukund
    Day, Ryan B.
    Wartman, Lukas D.
    Uy, Geoffrey L.
    Welch, John S.
    Christopher, Matthew J.
    Heath, Sharon E.
    Baty, Jack D.
    Schuelke, Matthew J.
    Payton, Jacqueline E.
    Spencer, David H.
    Rettig, Michael P.
    Link, Daniel C.
    Walter, Matthew J.
    Westervelt, Peter
    DiPersio, John F.
    Ley, Timothy J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (49)
12345